A comprehensive view of Fertility / Reproductive Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Clean beauty brand Saie launches second 'The Every Body' campaign, set to raise over US$300,000 for SisterSong: Women of Color Reproductive Justice Collective, a Black-women led membership organization dedicated to advancing reproductive justice

Sumitomo Pharma and Pfizer Canada announce availability of MYFEMBREE tablets in Canada; drug is available for management of moderate to severe pain from endometriosis in pre-menopausal women, management of heavy menstrual bleeding from uterine fibroids

Opill, the first OTC birth control pill approved in the US, is set to be launched by Perrigo in Q1 2024; many states are enacting laws that enable pharmacists to prescribe birth control without a doctor's prescription, with 29 states already allowing this

BioNTech and DualityBio receive FDA breakthrough therapy designation for antibody-drug conjugate candidate BNT323/DB-1303 in endometrial cancer; over 400,000 cases of endometrial or uterine cancer occurr each year worldwide

Ovia Health Unveils New Fertility and Family Building Benefit

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count